Vol 25 No 4 (2020)

Published December 11, 2020

Transformative Technologies Special Edition

Commentary

Arthur A Boni

What’s Coming Next in Transformative Innovation? Announcing “The Annual JCB Top 50 Organizations for Transformative Innovation in Biopharma, Med Tech and Digital Health”

Peter Pitts

A Healthcare Pilgrim's Progress

Articles

Arthur Boni, Dennis M. Gross

Emerging, Transformative Technologies: Promises and Business Model Challenges

Arthur A Boni

An introductory perspective on emerging, transformative technologies in biopharma: promises, challenges and impediments

Richard Murphey

A framework for comparing R&D productivity at big pharma companies vs. biotech startups

Saul Kaplan

Personalized Medicine by Design

Christopher Moehle, Jessica Gibson

Augmenting Healthcare with Human-Centered Technologies

John Baldoni, Edmon Begoli, Dimitri Kusnezov, John MacWilliams

Solving Hard Problems with AI: Dramatically Accelerating Drug Discovery Through A Unique Public-Private Partnership

Marc Watrous, PhD, Daniel S. Levine

Lessons from Sovaldi: Fueling Innovation While Ensuring Access

From the Boardroom

Arthur A Boni

The “Art of Collaborations”: Understanding the Anatomy of Transformative Transactions in Biopharma

Michael J. Kamdar , J. William Efcavitch

Commercializing the new frontier in DNA writing: Enzymatic synthesis

Arthur A Boni

Challenges for Transformative Innovation in Emerging Digital Health Organizations: advocating service design to address the multifaceted healthcare ecosystem

Amy Dow, Jennifer E. Michael , Lauren Sullivan

Legal and Compliance Considerations When Bringing Cellular Therapies to Market